Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

2.105 +0.145 (+7.40%)
Streaming Delayed Price Updated: 3:16 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
6 Analysts Have This to Say About Maravai LifeSciences
Via Benzinga
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
2 Biotech Stocks You Can Buy and Hold for the Next Decade
These two companies are facing short-term issues that are likely to give way to long-term success. 
Via The Motley Fool
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Where Maravai LifeSciences Stands With Analysts
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter: 
Via Benzinga
Analyst Ratings for Maravai LifeSciences
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter: 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 200 companies hit new 52-week lows. 
Via Benzinga
Recap: Maravai LifeSciences Q2 Earnings
Maravai LifeSciences (NASDAQ:MRVI) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
What 6 Analyst Ratings Have To Say About Maravai LifeSciences
Within the last quarter, Maravai LifeSciences (NASDAQ:MRVI) has observed the following analyst ratings: 
Via Benzinga
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning! 
Via InvestorPlace
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
Updates Revenue, Adjusted EBITDA and Adjusted EPS Guidance for 2022 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
This Fallen Growth Stock Is Still a Wall Street Favorite: Here's Why
It's positioned to benefit from the emergence of a new, long-term trend in biopharma. 
Via The Motley Fool
Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
   Losers 
Via Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 44 companies hit new 52-week lows. 
Via Benzinga
FaZe Holdings, AXT And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining more than 700 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Maravai LifeSciences Announces CEO Leadership Transition
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Genfit (NASDAQ:GNFT) shares increased by 27.4% to $5.12 during Thursday's after-market session. The market value of their outstanding shares is at $255.0 million. 
Via Benzinga
Earnings Outlook For Maravai LifeSciences
Maravai LifeSciences (NASDAQ:MRVI) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
Gainers 
Via Benzinga
5 Cheap Healthcare Stocks in 2022
Now, in the summer of 2022, healthcare stocks have been ignored and are cheap. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 297 companies achieved new lows for the year. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Upgrades 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.